サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375876

神経血管塞栓装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年

Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report By Product (Embolic Coils, Flow Diversion Devices), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
神経血管塞栓装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月05日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経血管塞栓装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、神経血管塞栓装置の世界市場規模は、2023年から2030年にかけてCAGR 6.60％を記録し、2030年には17億6,000万米ドルに達すると予測されています。

脳卒中発症率の増加、低侵襲手技の需要増、業界主要企業間の合併や提携が市場成長の原動力となっています。市場は、可処分所得が拡大し、ヘルスケアへのアクセスが改善された新興国で急成長しています。この結果、機器メーカーは新たな成長機会を得ており、世界の市場拡大が見込まれています。

世界中で脳卒中の有病率が上昇していることが、市場の成長を促す主な要因です。脳卒中は身体障害や死亡の主な原因の一つであり、世界人口の高齢化に伴い、糖尿病や高血圧などの脳卒中の危険因子がより一般的になっています。その結果、脳卒中の治療と予防に使用される神経血管塞栓術の必要性が高まっています。予測期間中、脳動脈瘤と脳卒中の有病率が世界市場の拡大に拍車をかけると予想されます。

例えば、世界脳卒中機構は、2022年までに脳卒中の有病率はすでに流行レベルに達していると予測しています。今年初めて脳卒中を経験した人は世界で1,220万人以上と推定され、その結果650万人が死亡し、25歳以上の成人の4人に1人が一生のうちに脳卒中にかかると予測されています。

神経血管塞栓術の技術開発が進み、治療の有効性と安全性が高まっています。主要な医療機器メーカーは、神経血管業界における製品ラインを拡大し、競合を増やし、技術革新を促進しています。主な業界プレーヤーは、業界成長を後押しする神経血管塞栓術分野の進歩のために、製品の製造や開発に携わっています。例えば、2023年2月、ドイツのEMBO-Post Market Surveillance Registryの最初の患者がShape Memory Medicalによって治療されました。末梢血管塞栓術は、IMPEDEおよびIMPEDE-FX塞栓プラグを使って、同社の視点、多施設登録調査から実施されました。

神経血管塞栓装置市場のハイライト

  • 2022年、塞栓コイル部門が77.66%の市場シェアを占めました。塞栓用コイル市場は、認知度の向上、治療方法の改善、コイル技術の新興国市場の開拓により、年々着実に拡大しています。
  • 最終用途別では、病院が2022年に71.87%と市場の大半を占めました。神経血管塞栓装置の使用は、神経血管疾患に関して病院が患者やその家族に教育する治療選択肢の1つです。病院がその能力を向上させ、最新の医療技術を導入し続けるにつれて、これらの機器に対する需要は引き続き堅調に推移すると予想されます。
  • 北米は2022年に26.44%のシェアを占め、市場を独占しました。同市場は競争が激しく、既存企業も新興企業も製品の革新、合併、買収、提携を通じて市場シェアの獲得に努めています。そのため、この地域の主要プレーヤーの存在が業界の成長を後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 神経血管塞栓装置市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 神経血管塞栓装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 神経血管塞栓装置市場：製品推定・動向分析

  • 定義と範囲
  • 製品市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 製品別の世界の神経血管塞栓装置市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで

第5章 神経血管塞栓装置市場：最終用途の推定・動向分析

  • 定義と範囲
  • 最終用途市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 最終用途別の神経血管塞栓装置市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで

第6章 神経血管塞栓装置市場：地域推定・動向分析

  • 地域市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2022年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 2018年から2030年の市場アプリケーション、予測および動向分析
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2022
    • Medtronic
    • Stryker
    • MicroVention Inc.
    • Cerenovus
    • Integra LifeSciences
    • Penumbra, Inc.
    • Balt SAS
    • B. Braun Melsungen AG
    • Phenox GmbH
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global neurovascular embolization devices market, by region 2018 - 2030 (USD Million)
  • Table 4. Global neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. North America neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. North America neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9. U.S. neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. U.S. neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11. Canada neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. Canada neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Europe neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
  • Table 14. Europe neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Europe neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. UK neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. UK neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18. Germany neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 19. Germany neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20. France neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. France neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22. Italy neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Italy neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24. Spain neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Spain neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. Denmark neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 27. Denmark neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28. Sweden neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Sweden neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30. Norway neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 31. Norway neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Japan neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 36. Japan neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37. China neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 38. China neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39. India neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 40. India neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41. Australia neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 42. Australia neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43. Thailand neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 44. Thailand neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45. South Korea neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 46. South Korea neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Latin America neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
  • Table 48. Latin America neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 49. Latin America neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50. Brazil neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 51. Brazil neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Mexico neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 53. Mexico neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Argentina neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 55. Argentina neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56. MEA neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
  • Table 57. MEA neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 58. MEA neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59. South Africa neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 60. South Africa neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. UAE neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 64. UAE neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
  • Table 66. Kuwait neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurovascular embolization devices market: Market snapshot
  • Fig. 9 Neurovascular embolization devices market: Market segmentation
  • Fig. 10 Neurovascular embolization devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurovascular embolization devices market driver impact
  • Fig. 14 Neurovascular embolization devices market restraint impact
  • Fig. 15 Neurovascular embolization devices market porter's five forces analysis
  • Fig. 16 Neurovascular embolization devices market PESTEL analysis
  • Fig. 17 Neurovascular embolization devices market segment dashboard
  • Fig. 18 Neurovascular embolization devices market: Product movement Analysis
  • Fig. 19 Embolic coils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Flow diversion devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Liquid embolic agents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Aneurysm clips market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Neurovascular embolization devices market segment dashboard
  • Fig. 24 Neurovascular embolization devices market: End-use movement Analysis
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Specialty clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global neurovascular embolization devices market: Regional movement analysis
  • Fig. 29 Global neurovascular embolization devices market: Regional outlook and key takeaways
  • Fig. 30 Global market share, by region
  • Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-131-9

Neurovascular Embolization Devices Market Growth & Trends:

The global neurovascular embolization devices market size is anticipated to reach USD 1.76 billion by 2030, registering a CAGR of 6.60% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increased stroke incidence, growth in demand for minimally invasive procedures, mergers and partnerships among the industry key players drives the market growth. The market is growing rapidly in developing nations with expanding disposable incomes and improved access to healthcare. Device manufacturers have new opportunities for growth as a result of this which is anticipated to expand the market globally.

The rising prevalence of stroke around the world is the main factor driving the growth of the market. Stroke is one of the main causes of disability and death, and as the world's population ages, risk factors for stroke, like diabetes and high blood pressure, are more common. The need for neurovascular embolization tools used in the treatment and prevention of strokes has increased as an outcome of this. Over the course of the projected period, it is anticipated that the prevalence of brain aneurysms and strokes will fuel global market expansion.

For instance, the World Stroke Organization predicted that by 2022, the prevalence of strokes already reached epidemic levels. Over 12.2 million people worldwide were estimated to experience a stroke for the first time this year, and 6.5 million deaths were projected as a result, with 1 out of every 4 adults over the age of 25 expected to suffer a stroke in their lifetime.

The effectiveness and safety of therapies have increased due to ongoing developments in neurovascular embolization technology. Leading medical device companies are expanding their product lines in the neurovascular industry, increasing rivalry and fostering innovation. The key industry players are involved in product manufacturing and development for the advancements in the neurovascular embolization sectors which boosts the industry growth. For instance, in February 2023, the German EMBO-Post Market Surveillance Registry's first patient was treated by Shape Memory Medical. Peripheral vascular embolization was carried out using the IMPEDE and IMPEDE-FX embolization plugs from the company's perspective, multicenter registry research.

Neurovascular Embolization Devices Market Highlights

  • In 2022, the embolic coils segment dominated with a market share of 77.66%. The embolic coils market has steadily expanded over the years as a result of rising awareness, bettering treatment methods, and developments in coil technology
  • Among end-use, hospitals held a majority share of the market of 71.87% in 2022. The use of neurovascular embolization devices is one of the treatment choices that hospitals educate patients and their families about when it comes to neurovascular diseases. As hospitals continue to improve their capabilities and adopt the latest medical technologies, the demand for these devices is expected to remain strong
  • North America dominated the market with a share of 26.44% in 2022. The market is competitive, with both established companies and emerging players striving to capture market share through product innovation, mergers, acquisitions, and partnerships. Thus, the presence of the key players in this region enhances the industry's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurovascular Embolization Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing incidence of neurovascular disorders
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Improved disease diagnostic techniques
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of devices
  • 3.5. Neurovascular Embolization Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurovascular Embolization Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Embolic Coils
    • 4.1.2. Flow Diversion Devices
    • 4.1.3. Liquid Embolic Agents
    • 4.1.4. Aneurysm Clips
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Neurovascular Embolization Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Embolic Coils
      • 4.5.1.1. Embolic coils market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Flow Diversion Devices
      • 4.5.2.1. Flow diversion devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Liquid Embolic Agents
      • 4.5.3.1. Liquid embolic agents market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Aneurysm Clips
      • 4.5.4.1. Aneurysm clips market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurovascular Embolization Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Specialty Clinics
    • 5.1.3. Others
  • 5.2. End-use Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurovascular Embolization Devices Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Specialty Clinics
      • 5.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurovascular Embolization Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2022
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive Scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive Scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive Scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive Scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive Scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive Scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Stryker
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MicroVention Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Cerenovus
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Integra LifeSciences
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Penumbra, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Balt SAS
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. B. Braun Melsungen AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Phenox GmbH
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives